Fetoscopic transuterine release of posterior urethral valves: A new technique
ABSTRACT Fetal urinary tract obstruction with oligohydramnios produces pulmonary hypoplasia and renal dysplasia. Decompression of the obstructed urinary tract may restore amniotic fluid and allow lung growth, but transabdominal catheter shunt decompression is often inadequate and does not allow for cycling of the bladder, while open procedures cause significant maternal morbidity. Disruption of the anatomic obstruction, usually posterior urethral valves in a male fetus, would be ideal but has proven technically difficult. Here we describe a new technique of percutaneous fetal cystoscopy and disruption of posterior urethral valves, and the case report of our first application of this technique. We pre-sent a case of a 17-week male fetus with posterior urethral valves which underwent fetal cystoscopy for mechanical disruption of posterior urethral valves. This minimally invasive approach to disruption of posterior urethral valves in a fetus is a novel method for decompressing the urinary tract. The technique offers a minimal degree of maternal morbidity and, if instituted early enough, can restore amniotic fluid volume, avert fatal pulmonary hypoplasia and may preserve renal function.
- SourceAvailable from: David M Lissauer[Show abstract] [Hide abstract]
ABSTRACT: Fetal lower urinary tract obstruction affects 2.2 per 10,000 births. It is a consequence of a range of pathological processes, most commonly posterior urethral valves (64%) or urethral atresia (39%). It is a condition of high mortality and morbidity associated with progressive renal dysfunction and oligohydramnios, and hence fetal pulmonary hypoplasia. Accurate detection is possible via ultrasound, but the underlying pathology is often unknown. In future, magnetic resonance imaging (MRI) may be increasingly used alongside ultrasound in the diagnosis and assessment of fetuses with lower urinary tract obstruction. Fetal urine analysis may provide improvements in prenatal determination of renal prognosis, but the optimum criteria to be used remain unclear. It is now possible to decompress the obstruction in utero via percutaneous vesico-amniotic shunting or cystoscopic techniques. In appropriately selected fetuses intervention may improve perinatal survival, but long-term renal morbidity amongst survivors remains problematic.Seminars in Fetal and Neonatal Medicine 01/2008; 12(6):464-70. DOI:10.1016/j.siny.2007.06.005 · 3.13 Impact Factor
Chapter: Fetal Surgery[Show abstract] [Hide abstract]
ABSTRACT: The first open maternal-fetal operation was performed nearly 30 years ago. The indications for intervention have remained largely constant from the first decade of fetal surgery to the start of the fourth decade and the basic tenets of fetal surgery also have remained consistent. The three basic tenets are: (1) the pregnant woman should undergo minimal risk to her health; (2) the fetal disease should be severe and progressive; and (3) fetal intervention should have a high likelihood for reversing fetal disease. While the diseases treated have remained the same, the approach to fetal interventions has changed dramatically. Initial fetal surgical procedures depended on maternal laparotomy and hysterotomy. This approach evolved into maternal laparotomy with uterine endoscopy and most recently into percutaneous approaches. It appears that the less invasive approaches are associated with a less complicated postoperative recovery for the mother, but morbidity is not eliminated.Management of High-Risk Pregnancy: An Evidence-Based Approach, Fifth Edition, 04/2008: pages 433 - 441; , ISBN: 9780470691878
- [Show abstract] [Hide abstract]
ABSTRACT: To report the experience with fetal cystoscopy and laser fulguration of posterior urethral values (PUV) for severe lower urinary tract obstruction (LUTO). Between July 2006 and December 2008, fetal cystoscopy was offered to 23 patients whose fetuses presented with severe LUTO, favorable urinary analysis and gestational age <26 weeks. Fetal urinary biochemistry was evaluated before and after cystoscopy. All infants were followed 6-12 months after birth. Abnormal renal function was defined when serum creatinine higher than 50 micromol/L (2 Standard Deviation) or the necessity of dialysis or renal transplantation. Autopsy was always performed whenever fetal or neonatal deaths occurred. Eleven patients decided to undergo fetal therapy and 12 elected to continue with expectant observation. There was no difference between both groups in gestation age at diagnosis and referral examinations. Urethral atresia was diagnosed in 4/11 (36.4%) fetuses by fetal cystoscopy. At 26 weeks, fetuses that were managed expectantly presented with worse urinary biochemistry results (p < 0.05). Survival rates and percentage of infants with normal renal function were significantly higher in the cystoscopic group than in the expectant group (p < 0.05). Percutaneous fetal cystoscopy is feasible using a thinner special cannula for prenatal diagnosis and therapy of LUTO. Prenatal laser ablation of the PUV under cystoscopy may prevent renal function deterioration improving postnatal outcome.Prenatal Diagnosis 11/2009; 30(1):30-9. DOI:10.1002/pd.2418 · 3.27 Impact Factor